News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
A Perspective on the MARS2 Trial, by Eric Lim
Eric Lim/vjoncology.com
Jan 15, 2025, 14:23

A Perspective on the MARS2 Trial, by Eric Lim

Oscar Tahuahua, Medical Oncology fellow at National Cancer Institute, shared an article by Eric Lim on X:

“A Perspective on the MARS2 Trial.

Is mesothelioma a surgical disease?

The MARS2 trial shows higher mortality and adverse events without improving survival. Risks increase outside high-volume centers, limiting benefits to specific subgroups.” 

A Perspective on the MARS2 Trial, by Eric Lim

A Perspective on the MARS2 Trial.

Authors: Eric Lim, et al.

A Perspective on the MARS2 Trial, by Eric Lim

cancer Eric Lim fight against cancer Global fight against cancer Instituto Nacional de Cancerología MARS2 Trial MedOnc mesothelioma OncoDaily Oncology Oscar Tahuahua
Special Coverage
Drugs
Aug 8, 2025, 07:08
Adagrasib (Krazati) Updates 2025: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Career
Aug 8, 2025, 06:20
Joseph Contessa Selected as the Chair of Radiation Oncology at Rutgers Cancer Institute
Dialogues
Aug 8, 2025, 06:16
Accelerating Cancer Drug Development with AI: Interview with Dr. Jen-Tang (JT) Lu from Vysioneer
Blog
Aug 8, 2025, 06:08
Better-Targeted Therapies for Patients with Acute Myeloid Leukemia - IU Simon Comprehensive Cancer Center
Blog
Aug 8, 2025, 05:59
The Silver Jubilee of the Townsville to Cairns Bike Ride: Raising Funds for Childhood Cancer - Children's Cancer Institute
Insight
Aug 8, 2025, 05:47
FASCO 2025: 97 Voices, One Mission: Part 2
Science
Aug 8, 2025, 05:44
Yan Leyfman: Turning Paradoxical Biology Into Precision Immunotherapy Opportunities
Science
Aug 8, 2025, 05:01
Arndt Vogel: ESMO-MCBS 2.0 Scorecards for Hepatocellular Carcinoma
Oncolibrary
Aug 8, 2025, 03:13
CAR T-Cell Therapy vs iNKT Cell Therapy: The Future of Engineered Immune Cells in Cancer Treatment
Oncolibrary
Aug 8, 2025, 03:09
Immunotherapy for Cancer Success Rate: What Patients Need to Know in 2025
Oncolibrary
Aug 8, 2025, 01:07
10-Minute Immunotherapy Infusion: Safe, Efficient Delivery of Nivolumab and Pembrolizumab
Societies
Aug 7, 2025, 23:50
Because Every Patient Matters: Promoting Diversity in Cancer Support - MASCC